Recap: Kala Pharmaceuticals Q1 Earnings


Kala Pharmaceuticals KALA reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.


Kala Pharmaceuticals missed estimated earnings by 11.11%, reporting an EPS of $-0.4 versus an estimate of $-0.36.

Revenue was down $1.89 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.27 which was followed by a 2.67% drop in the share price the next day.

Here's a look at Kala Pharmaceuticals's past performance:


Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.41 -0.43 -0.45 -0.68
EPS Actual -0.68 -0.43 -0.57 -0.49
Revenue Estimate 3.41M 5.16M 5.33M 4.18M
Revenue Actual 1.86M 3.07M 3.05M 3.27M

To track all earnings releases for Kala Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarningsNews